Bleeding disorders in neonates

Haemophilia

Volumn 16, Issue SUPPL. 5, 2010, Pages 168-175

  Kenet, G ^a   Chan, A K C ^b   Soucie, J M ^c   Kulkarni, R ^d  

^a SHEBA MEDICAL CENTER   (Israel)

^b MCMASTER UNIVERSITY   (Canada)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Developmental haemostasis; Haemophilia; Intracranioal haemorrhage; Neonates

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; FIBRINOGEN; FRESH FROZEN PLASMA; HIGH MOLECULAR WEIGHT KININOGEN; PREKALLIKREIN; PROTHROMBIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP; VON WILLEBRAND FACTOR;

BIRTH; BLEEDING DISORDER; BLEEDING TIME; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BRAIN HEMORRHAGE; CLINICAL EVALUATION; CRYOPRECIPITATE; DELIVERY; FAMILY HISTORY; FIBRINOGEN BLOOD LEVEL; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; LABORATORY TEST; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN DISEASE; NEWBORN MORBIDITY; PARTIAL THROMBOPLASTIN TIME; PERINATAL PERIOD; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; REVIEW; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; VITAMIN K DEFICIENCY;

BLOOD COAGULATION FACTORS; BLOOD PLATELETS; FAMILY HEALTH; HEMOPHILIA A; HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; INCIDENCE; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; PRENATAL DIAGNOSIS;

EID: 77955021640     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02316.x     Document Type: Review

References (37)

1. Skogen B, Husebekk A, Killie MK, Kjeldsen-Kragh J. Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from large prospective screening and intervention program. Scand J Immunol 2009, 70:531-4.
2. Motta M, Tincani A, Lojacono A. Neonatal outcome in patients with rheumatic disease. Lupus 2004, 13:718-23.
3. Hancock JF, Wieland K, Pugh RE. A molecular genetic study of factor XI deficiency. Blood 1991, 77:1942-8.
4. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001, 112:851-62.
5. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994, 84:1650-5.
6. Reverdiau-Moalic P, Delahousse B, Bardos P. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996, 88:900-6.
7. Andrew M, Payes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990, 12:95-104.
8. Andrew M, Vegh P, Johnston M. Maturation of the hemostatic system during childhood. Blood 1992, 80:1998-2005.
9. Cvirn G, Gallistl S, Muntean W. Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb Res 1999, 93:183-90.
10. Andrew M, Schmidt B, Mitchell L. Thrombin generation in newborn plasma is critically dependant on the concentration of prothrombin. Thromb Haemost 1990, 63:27-30.
11. Monagle P, Barnes C, Ignjatovic V. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006, 95:362-72.
12. Witt I, Müller H, Künzer W. Evidence for the existence of fetal fibrinogen. Thromb Diath Haemorrh 1969, 22:101-9.
13. Katz JA, Moake JL, McPherson PD. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989, 73:1851-8.
14. Saxonhouse MA, Sola MC. Platelet function in term and preterm neonates. Clin Perinatol 2004, 31:15-28.
15. Levy-Shraga Y, Maayan-Metzger A, Lubetsky A. Platelet function of newborns as tested by the Cone and Plate(let) analyser correlates with gestational age. Acts Haematol 2006, 115:152-6.
16. Khair K, Liessner R. Bruising and bleeding in infants and children - a practical approach. Br J Haematol 2006, 133:221-31.
17. Chalmers E. Haemophilia and the newborn. Blood Rev 2004, 18:85-92.
18. Ljung R. The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery. Haemophilia 2009, 16:415-19.
19. James AH, Hoots K. The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery. Haemophilia 2009, 16:420-4.
20. Kulkarni R, Soucie JM, Presley R. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed the age of two years: a report from the Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia 2009, 15:1281-90.
21. Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol 2008, 140:378-84.
22. Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia. Br J Haematol 2001, 112:264-74.
23. Gupta SN, Kechli AM, Kanamalla US. Intracranial hemorrhage in term newborns: management and outcomes. Pediatr Neurol 2009, 40:1-12.
24. Riskin A, Riskin-Mashiah S, Bader D. Delivery mode and severe intraventricular hemorrhage in single, very low birth weight, vertex infants. Obstet Gynecol 2008, 112:21-8.
25. Looney CB, Smith JK, Merck LH. Intracranial hemorrhage in asymptomatic neonates: prevalence on MR images and relationship to obstetric and neonatal risk factors. Radiology 2007, 242:535-41.
26. Tarantino MD, Gupta SL, Brusky RM. The incidence and outcome of intracranial haemorrhage in newborns with haemophilia: analysis of the Nationwide Inpatient Sample database. Haemophilia 2007, 13:380-2.
27. Ljung R, Chambost H, Stain AM, DiMichele D. Haemophilia in the first years of life. Haemophilia 2008, 3:188-95.
28. Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol 1999, 21:289-95.
29. Smith AR, Leonard N, Kurth MH. Intracranial hemorrhage in newborns with hemophilia: the role of screening radiologic studies in the first 7 days of life. J Pediatr Hematol Oncol 2008, 30:81-4.
30. Nelson MD, Maeder MA, Usner D, Mitchell WG, Fenstermacher MJ, Wilson DA, Gomperts ED. Prevalence and incidence of intracranial haemonhage in a population of children with haemiphilia. The Haemophilia Growth and Development Study. Haemophilia 1999, 5:306-12.
31. Eyster ME, Gill FM, Blatt PM, Hilgartner MW, Ballard JO, Kinney TR. Central nervous system bleeding in hemophiliacs. Blood 1978, 51:1179-88.
32. Stieltjes N, Calvez T, Demiguel V. Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death. Haemophilia 2005, 11:452-8.
33. Chalmers EA, Brown SA, Keeling D. Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A. Haemophilia 2007, 13:149-55.
34. Gouw SC, van der Bom JG, Marijke van den Berg H. Treatment-related riskfactors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood 2007, 109:4648-54.
35. Brettlet D, Levine P. Clinical manifestations and therapy of inherited coagulation factor deficiencies. Hemostasis and Thrombosis: Basic Principles and Clinical Practice 1999, 169-83. Colman RW, Hirsh JMarder VJSalzman EW. eds, 3rd edn, Philadelphia, J.B Lippincott Company
36. Brady KM, Easley EB, Tobias JD. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Paediatr Anaesth 2006, 16:1042-6.
37. Sanchez-Garcia JF, Gallardo D, Ramirez L, Vidal F. A versatile strategy for preimplantation genetic diagnosis of haemophilia A based on F8-gene sequencing. Thromb Haemost 2006, 96:839-45.